{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:01:39Z","timestamp":1776056499295,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":620,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41379-020-00720-7","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T11:02:44Z","timestamp":1607770964000},"page":"904-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-4116","authenticated-orcid":false,"given":"Adam R.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda R.","family":"Oran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn T.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.D.","family":"Morrissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-00720-7_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1038\/s41379-020-00720-7_bib2","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia."},{"key":"10.1038\/s41379-020-00720-7_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fonc.2019.00321","article-title":"The role of new technologies in myeloproliferative neoplasms","volume":"9","author":"Palumbo","year":"2019","journal-title":"Front Oncol"},{"key":"10.1038\/s41379-020-00720-7_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal hematopoiesis to secondary leukemia","volume":"17","author":"Sperling","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-020-00720-7_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib9","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3109\/10428194.2016.1173212","article-title":"Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets","volume":"57","author":"Bogusz","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/s41379-020-00720-7_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1182\/asheducation-2018.1.69","article-title":"Genomics of aggressive B-cell lymphoma","volume":"2018","author":"Rosenthal","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1038\/s41379-020-00720-7_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-020-00720-7_bib14","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00720-7_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib16","first-page":"11770","article-title":"Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1038\/s41379-020-00720-7_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1038\/s41379-020-00720-7_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-00720-7_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOH.0000000000000520","article-title":"Using genomic data for selecting the treatment of lymphoma patients","volume":"26","author":"Batlevi","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/s41379-020-00720-7_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2016.71.7603","article-title":"Clinical applications of the genomic landscape of aggressive non-Hodgkin lymphoma","volume":"35","author":"Moffitt","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00720-7_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-020-00720-7_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20892\/j.issn.2095-3941.2018.0055","article-title":"Next-generation sequencing and its clinical application","volume":"16","author":"Qin","year":"2019","journal-title":"Cancer Biol Med"},{"key":"10.1038\/s41379-020-00720-7_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2017-03-734533","article-title":"The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice","volume":"130","author":"Kuo","year":"2017","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.seminhematol.2018.05.006","article-title":"Next generation sequencing in hematolymphoid neoplasia","volume":"56","author":"Kuo","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1038\/s41379-020-00720-7_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cancers11010011","article-title":"Comprehensive genomic profiling reveals diverse but actionable molecular portfolios across hematologic malignancies: Implications for next generation clinical trials","volume":"11","author":"Galanina","year":"2018","journal-title":"Cancers"},{"key":"10.1038\/s41379-020-00720-7_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0644-8","article-title":"Clinical utility of custom-designed NGS panel testing in pediatric tumors","volume":"11","author":"Surrey","year":"2019","journal-title":"Genome Med"},{"key":"10.1038\/s41379-020-00720-7_bib27","doi-asserted-by":"crossref","unstructured":"Pillonel V, Juskevicius D, Bihl M, Stenner F, Halter JP, Dirnhofer S, et al. Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-year practical experience. Leuk Lymphoma. 2020;61:2568\u201383.","DOI":"10.1080\/10428194.2020.1786560"},{"key":"10.1038\/s41379-020-00720-7_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-020-00720-7_bib29","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1038\/s41379-020-00720-7_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.beha.2019.06.003","article-title":"Genomics of LGL leukemia and select other rare leukemia\/lymphomas","volume":"32","author":"Moosic","year":"2019","journal-title":"Best Pr Res Clin Haematol"},{"key":"10.1038\/s41379-020-00720-7_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2019","journal-title":"Haematologica."},{"key":"10.1038\/s41379-020-00720-7_bib32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib33","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood-2016-03-704528","article-title":"Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma","volume":"128","author":"Mansouri","year":"2016","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neo.2018.08.012","article-title":"Analysis of genomic alteration in primary central nervous system lymphoma and the expression of some related genes","volume":"20","author":"Zhou","year":"2018","journal-title":"Neoplasia."},{"key":"10.1038\/s41379-020-00720-7_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/ijms17050683","article-title":"Gene mutation profiles in primary diffuse large B cell lymphoma of central nervous system: next generation sequencing analyses","volume":"17","author":"Balint","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41379-020-00720-7_bib37","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2002-02-0382","article-title":"ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma","volume":"100","author":"Gr\u00f8nbaek","year":"2002","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.leu.2403221","article-title":"ATM gene and lymphoid malignancies","volume":"18","author":"Gumy-Pause","year":"2004","journal-title":"Leukemia."},{"key":"10.1038\/s41379-020-00720-7_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-00720-7_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","article-title":"Chromatin modifying gene mutations in follicular lymphoma","volume":"131","author":"Green","year":"2018","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-020-00720-7_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.20142009","article-title":"Functional loss of I\u03baB\u03b5 leads to NF-\u03baB deregulation in aggressive chronic lymphocytic leukemia","volume":"212","author":"Mansouri","year":"2015","journal-title":"J Exp Med"},{"key":"10.1038\/s41379-020-00720-7_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia."},{"key":"10.1038\/s41379-020-00720-7_bib44","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-020-00720-7_bib45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3324\/haematol.2018.196931","article-title":"Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia","volume":"104","author":"Gim\u00e9nez","year":"2019","journal-title":"Haematologica."},{"key":"10.1038\/s41379-020-00720-7_bib46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.2019000854","article-title":"Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study","volume":"134","author":"Quinquenel","year":"2019","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.2016.70.2282","article-title":"BTKC481S-mediated resistance to ibrutinib in chronic lymphocytic leukemia","volume":"35","author":"Woyach","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00720-7_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature."},{"key":"10.1038\/s41379-020-00720-7_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature."},{"key":"10.1038\/s41379-020-00720-7_bib50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","article-title":"Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations","volume":"127","author":"Ljungstr\u00f6m","year":"2016","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib51","doi-asserted-by":"crossref","first-page":"814294","DOI":"10.1155\/2014\/814294","article-title":"TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations","volume":"2014","author":"Hern\u00e1ndez-S\u00e1nchez","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1038\/s41379-020-00720-7_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature."},{"key":"10.1038\/s41379-020-00720-7_bib53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell."},{"key":"10.1038\/s41379-020-00720-7_bib54","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-020-00720-7_bib55","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia."},{"key":"10.1038\/s41379-020-00720-7_bib56","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.18632\/oncotarget.14928","article-title":"The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP","volume":"8","author":"Jung","year":"2017","journal-title":"Oncotarget."},{"key":"10.1038\/s41379-020-00720-7_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3343\/alm.2015.35.2.257","article-title":"BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases","volume":"35","author":"Shin","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1038\/s41379-020-00720-7_bib58","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1038\/s41379-020-00720-7_bib59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"key":"10.1038\/s41379-020-00720-7_bib60","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.3324\/haematol.2013.101543","article-title":"STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression","volume":"99","author":"Ohgami","year":"2014","journal-title":"Haematologica."},{"key":"10.1038\/s41379-020-00720-7_bib61","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjh.13361","article-title":"MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity","volume":"169","author":"Schmidt","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-020-00720-7_bib63","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-17-0007","article-title":"TP53 mutation and its prognostic significance in waldenstrom's macroglobulinemia","volume":"23","author":"Poulain","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00720-7_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34\u2013expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-00720-7_bib65","first-page":"4014","article-title":"Molecular characterization of post-transplant plasmablastic lymphomas implicates RAS, TP53, and NOTCH mutations and MYC deregulation in disease pathogenesis","volume":"130","author":"Leeman-Neill","year":"2017","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib66","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjh.15653","article-title":"Detailed molecular analysis and evaluation of prognosis in cases with high grade b\u2010cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"185","author":"Stengel","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-020-00720-7_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10428194.2014.907896","article-title":"TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations","volume":"56","author":"Gebauer","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/s41379-020-00720-7_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bjh.14633","article-title":"Mutational landscape of b\u2010cell post\u2010transplant lymphoproliferative disorders","volume":"178","author":"Menter","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-020-00720-7_bib69","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/modpathol.2016.130","article-title":"EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations","volume":"29","author":"Courville","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00720-7_bib70","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1158\/1078-0432.CCR-15-1790","article-title":"The spectrum and clinical impact of epigenetic modifier mutations in myeloma","volume":"22","author":"Pawlyn","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00720-7_bib71","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood.V116.21.4992.4992","article-title":"IDH1 and IDH2 mutations are not frequent in multiple myeloma","volume":"116","author":"Langer","year":"2010","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00019","article-title":"Genomic profiling of T-cell neoplasms reveals frequent JAK1 and JAK3 mutations with clonal evasion from targeted therapies","volume":"2018","author":"Greenplate","year":"2018","journal-title":"JCO Precis Oncol."},{"key":"10.1038\/s41379-020-00720-7_bib73","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib74","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant\u2010associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-020-00720-7_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-017-0582-9","article-title":"Genetic landscape and classification of peripheral T cell lymphomas","volume":"19","author":"Sandell","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1038\/s41379-020-00720-7_bib76","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-00720-7_bib77","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/PAI.0000000000000683","article-title":"High-throughput sequencing of subcutaneous panniculitis-like T-cell lymphoma reveals candidate pathogenic mutations","volume":"27","author":"Fernandez-Pol","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-020-00720-7_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK\u2013STAT pathway in s\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-020-00720-7_bib79","doi-asserted-by":"crossref","first-page":"e0173171","DOI":"10.1371\/journal.pone.0173171","article-title":"TP53 alterations in primary and secondary s\u00e9zary syndrome: a diagnostic tool for the assessment of malignancy in patients with erythroderma","volume":"12","author":"Gros","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-020-00720-7_bib80","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and s\u00e9zary syndrome","volume":"47","author":"Da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-00720-7_bib81","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia."},{"key":"10.1038\/s41379-020-00720-7_bib82","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood."},{"key":"10.1038\/s41379-020-00720-7_bib83","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-00720-7_bib84","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood."}],"updated-by":[{"DOI":"10.1038\/s41379-020-00733-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00720-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T23:56:52Z","timestamp":1724025412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0893395222006202"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-00720-7","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/s41379-020-00733-2","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-00720-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-00733-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}